> top > docs > PubMed:25527429 > annotations

PubMed:25527429 JSONTXT

Annnotations TAB JSON ListView MergeView

Glycan-Motif

Id Subject Object Predicate Lexical cue
T1 847-857 https://glytoucan.org/Structures/Glycans/G57321FI denotes Tn antigen
T2 990-996 https://glytoucan.org/Structures/Glycans/G00031MO denotes core 1
T3 997-1010 https://glytoucan.org/Structures/Glycans/G17108EX denotes blood group A
T4 997-1010 https://glytoucan.org/Structures/Glycans/G58507AZ denotes blood group A
T5 1756-1766 https://glytoucan.org/Structures/Glycans/G57321FI denotes Tn antigen

Inflammaging

Id Subject Object Predicate Lexical cue
T1 0-98 Sentence denotes Single molecule study of heterotypic interactions between mucins possessing the Tn cancer antigen.
T2 99-266 Sentence denotes Mucins are linear, heavily O-glycosylated proteins with physiological roles that include cell signaling, cell adhesion, inflammation, immune response and tumorgenesis.
T3 267-368 Sentence denotes Cancer-associated mucins often differ from normal mucins by presenting truncated carbohydrate chains.
T4 369-594 Sentence denotes Characterization of the binding properties of mucins with truncated carbohydrate side chains could thus prove relevant for understanding their role in cancer mechanisms such as metastasis and recognition by the immune system.
T5 595-822 Sentence denotes In this work, heterotypic interactions of model mucins that possess the Tn (GalNAcαThr/Ser) and T (Galβ1-3GalNAcαThr/Ser) cancer antigens derived from porcine submaxillary mucin (PSM) were studied using atomic force microscopy.
T6 823-1071 Sentence denotes PSM possessing only the Tn antigen (Tn-PSM) was found to bind to PSM analogs possessing a combination of T, Tn and STn antigens as well as biosynthetic analogs of the core 1 blood group A tetrasaccharide (GalNAcα1-3[Fucα1-2] Galβ1-3GalNAcαSer/Thr).
T7 1072-1186 Sentence denotes The rupture forces for the heterotypic interactions ranged from 18- to 31 pN at a force-loading rate of ∼0.5 nN/s.
T8 1187-1419 Sentence denotes The thermally averaged distance from the bound complex to the transition state (xβ) was estimated to be in the range 0.37-0.87 nm for the first barrier of the Bell Evans analysis and within 0.34-0.64 nm based on a lifetime analysis.
T9 1420-1593 Sentence denotes These findings reveal that the binding strength and energy landscape for heterotypic interactions of Tn-PSM with the above mucins, resemble homotypic interactions of Tn-PSM.
T10 1594-1783 Sentence denotes This suggests common carbohydrate epitope interactions for the Tn cancer antigen with the above mucin analogs, a finding that may be important to the role of the Tn antigen in cancer cells.
T1 0-98 Sentence denotes Single molecule study of heterotypic interactions between mucins possessing the Tn cancer antigen.
T2 99-266 Sentence denotes Mucins are linear, heavily O-glycosylated proteins with physiological roles that include cell signaling, cell adhesion, inflammation, immune response and tumorgenesis.
T3 267-368 Sentence denotes Cancer-associated mucins often differ from normal mucins by presenting truncated carbohydrate chains.
T4 369-594 Sentence denotes Characterization of the binding properties of mucins with truncated carbohydrate side chains could thus prove relevant for understanding their role in cancer mechanisms such as metastasis and recognition by the immune system.
T5 595-822 Sentence denotes In this work, heterotypic interactions of model mucins that possess the Tn (GalNAcαThr/Ser) and T (Galβ1-3GalNAcαThr/Ser) cancer antigens derived from porcine submaxillary mucin (PSM) were studied using atomic force microscopy.
T6 823-1071 Sentence denotes PSM possessing only the Tn antigen (Tn-PSM) was found to bind to PSM analogs possessing a combination of T, Tn and STn antigens as well as biosynthetic analogs of the core 1 blood group A tetrasaccharide (GalNAcα1-3[Fucα1-2] Galβ1-3GalNAcαSer/Thr).
T7 1072-1186 Sentence denotes The rupture forces for the heterotypic interactions ranged from 18- to 31 pN at a force-loading rate of ∼0.5 nN/s.
T8 1187-1419 Sentence denotes The thermally averaged distance from the bound complex to the transition state (xβ) was estimated to be in the range 0.37-0.87 nm for the first barrier of the Bell Evans analysis and within 0.34-0.64 nm based on a lifetime analysis.
T9 1420-1593 Sentence denotes These findings reveal that the binding strength and energy landscape for heterotypic interactions of Tn-PSM with the above mucins, resemble homotypic interactions of Tn-PSM.
T10 1594-1783 Sentence denotes This suggests common carbohydrate epitope interactions for the Tn cancer antigen with the above mucin analogs, a finding that may be important to the role of the Tn antigen in cancer cells.

GlyCosmos6-Glycan-Motif-Image

Id Subject Object Predicate Lexical cue image
T1 847-857 Glycan_Motif denotes Tn antigen https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G57321FI
T2 990-996 Glycan_Motif denotes core 1 https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00031MO
T3 997-1010 Glycan_Motif denotes blood group A https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G58507AZ|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G17108EX
T5 1756-1766 Glycan_Motif denotes Tn antigen https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G57321FI

GlyCosmos6-Glycan-Motif-Structure

Id Subject Object Predicate Lexical cue
T1 847-857 https://glytoucan.org/Structures/Glycans/G57321FI denotes Tn antigen
T2 990-996 https://glytoucan.org/Structures/Glycans/G00031MO denotes core 1
T3 997-1010 https://glytoucan.org/Structures/Glycans/G17108EX denotes blood group A
T4 997-1010 https://glytoucan.org/Structures/Glycans/G58507AZ denotes blood group A
T5 1756-1766 https://glytoucan.org/Structures/Glycans/G57321FI denotes Tn antigen

sentences

Id Subject Object Predicate Lexical cue
TextSentencer_T1 0-98 Sentence denotes Single molecule study of heterotypic interactions between mucins possessing the Tn cancer antigen.
TextSentencer_T2 99-266 Sentence denotes Mucins are linear, heavily O-glycosylated proteins with physiological roles that include cell signaling, cell adhesion, inflammation, immune response and tumorgenesis.
TextSentencer_T3 267-368 Sentence denotes Cancer-associated mucins often differ from normal mucins by presenting truncated carbohydrate chains.
TextSentencer_T4 369-594 Sentence denotes Characterization of the binding properties of mucins with truncated carbohydrate side chains could thus prove relevant for understanding their role in cancer mechanisms such as metastasis and recognition by the immune system.
TextSentencer_T5 595-822 Sentence denotes In this work, heterotypic interactions of model mucins that possess the Tn (GalNAcαThr/Ser) and T (Galβ1-3GalNAcαThr/Ser) cancer antigens derived from porcine submaxillary mucin (PSM) were studied using atomic force microscopy.
TextSentencer_T6 823-1071 Sentence denotes PSM possessing only the Tn antigen (Tn-PSM) was found to bind to PSM analogs possessing a combination of T, Tn and STn antigens as well as biosynthetic analogs of the core 1 blood group A tetrasaccharide (GalNAcα1-3[Fucα1-2] Galβ1-3GalNAcαSer/Thr).
TextSentencer_T7 1072-1186 Sentence denotes The rupture forces for the heterotypic interactions ranged from 18- to 31 pN at a force-loading rate of ∼0.5 nN/s.
TextSentencer_T8 1187-1419 Sentence denotes The thermally averaged distance from the bound complex to the transition state (xβ) was estimated to be in the range 0.37-0.87 nm for the first barrier of the Bell Evans analysis and within 0.34-0.64 nm based on a lifetime analysis.
TextSentencer_T9 1420-1593 Sentence denotes These findings reveal that the binding strength and energy landscape for heterotypic interactions of Tn-PSM with the above mucins, resemble homotypic interactions of Tn-PSM.
TextSentencer_T10 1594-1783 Sentence denotes This suggests common carbohydrate epitope interactions for the Tn cancer antigen with the above mucin analogs, a finding that may be important to the role of the Tn antigen in cancer cells.
T1 0-98 Sentence denotes Single molecule study of heterotypic interactions between mucins possessing the Tn cancer antigen.
T2 99-266 Sentence denotes Mucins are linear, heavily O-glycosylated proteins with physiological roles that include cell signaling, cell adhesion, inflammation, immune response and tumorgenesis.
T3 267-368 Sentence denotes Cancer-associated mucins often differ from normal mucins by presenting truncated carbohydrate chains.
T4 369-594 Sentence denotes Characterization of the binding properties of mucins with truncated carbohydrate side chains could thus prove relevant for understanding their role in cancer mechanisms such as metastasis and recognition by the immune system.
T5 595-822 Sentence denotes In this work, heterotypic interactions of model mucins that possess the Tn (GalNAcαThr/Ser) and T (Galβ1-3GalNAcαThr/Ser) cancer antigens derived from porcine submaxillary mucin (PSM) were studied using atomic force microscopy.
T6 823-1071 Sentence denotes PSM possessing only the Tn antigen (Tn-PSM) was found to bind to PSM analogs possessing a combination of T, Tn and STn antigens as well as biosynthetic analogs of the core 1 blood group A tetrasaccharide (GalNAcα1-3[Fucα1-2] Galβ1-3GalNAcαSer/Thr).
T7 1072-1186 Sentence denotes The rupture forces for the heterotypic interactions ranged from 18- to 31 pN at a force-loading rate of ∼0.5 nN/s.
T8 1187-1419 Sentence denotes The thermally averaged distance from the bound complex to the transition state (xβ) was estimated to be in the range 0.37-0.87 nm for the first barrier of the Bell Evans analysis and within 0.34-0.64 nm based on a lifetime analysis.
T9 1420-1593 Sentence denotes These findings reveal that the binding strength and energy landscape for heterotypic interactions of Tn-PSM with the above mucins, resemble homotypic interactions of Tn-PSM.
T10 1594-1783 Sentence denotes This suggests common carbohydrate epitope interactions for the Tn cancer antigen with the above mucin analogs, a finding that may be important to the role of the Tn antigen in cancer cells.
T1 0-98 Sentence denotes Single molecule study of heterotypic interactions between mucins possessing the Tn cancer antigen.
T2 99-266 Sentence denotes Mucins are linear, heavily O-glycosylated proteins with physiological roles that include cell signaling, cell adhesion, inflammation, immune response and tumorgenesis.
T3 267-368 Sentence denotes Cancer-associated mucins often differ from normal mucins by presenting truncated carbohydrate chains.
T4 369-594 Sentence denotes Characterization of the binding properties of mucins with truncated carbohydrate side chains could thus prove relevant for understanding their role in cancer mechanisms such as metastasis and recognition by the immune system.
T5 595-822 Sentence denotes In this work, heterotypic interactions of model mucins that possess the Tn (GalNAcαThr/Ser) and T (Galβ1-3GalNAcαThr/Ser) cancer antigens derived from porcine submaxillary mucin (PSM) were studied using atomic force microscopy.
T6 823-1071 Sentence denotes PSM possessing only the Tn antigen (Tn-PSM) was found to bind to PSM analogs possessing a combination of T, Tn and STn antigens as well as biosynthetic analogs of the core 1 blood group A tetrasaccharide (GalNAcα1-3[Fucα1-2] Galβ1-3GalNAcαSer/Thr).
T7 1072-1186 Sentence denotes The rupture forces for the heterotypic interactions ranged from 18- to 31 pN at a force-loading rate of ∼0.5 nN/s.
T8 1187-1419 Sentence denotes The thermally averaged distance from the bound complex to the transition state (xβ) was estimated to be in the range 0.37-0.87 nm for the first barrier of the Bell Evans analysis and within 0.34-0.64 nm based on a lifetime analysis.
T9 1420-1593 Sentence denotes These findings reveal that the binding strength and energy landscape for heterotypic interactions of Tn-PSM with the above mucins, resemble homotypic interactions of Tn-PSM.
T10 1594-1783 Sentence denotes This suggests common carbohydrate epitope interactions for the Tn cancer antigen with the above mucin analogs, a finding that may be important to the role of the Tn antigen in cancer cells.

Glycosmos6-GlycoEpitope

Id Subject Object Predicate Lexical cue
T1 847-857 http://www.glycoepitope.jp/epitopes/EP0021 denotes Tn antigen
T2 1756-1766 http://www.glycoepitope.jp/epitopes/EP0021 denotes Tn antigen

Glycosmos6-MAT

Id Subject Object Predicate Lexical cue
T1 997-1002 http://purl.obolibrary.org/obo/MAT_0000083 denotes blood
T2 997-1002 http://purl.obolibrary.org/obo/MAT_0000315 denotes blood

Glycan-GlyCosmos

Id Subject Object Predicate Lexical cue image
T1 671-677 Glycan denotes GalNAc https://api.glycosmos.org/wurcs2image/latest/png/binary/G39738WL
T2 701-707 Glycan denotes GalNAc https://api.glycosmos.org/wurcs2image/latest/png/binary/G39738WL
T3 847-857 Glycan denotes Tn antigen https://api.glycosmos.org/wurcs2image/latest/png/binary/G57321FI
T4 990-996 Glycan denotes core 1 https://api.glycosmos.org/wurcs2image/latest/png/binary/G00031MO
T5 1028-1034 Glycan denotes GalNAc https://api.glycosmos.org/wurcs2image/latest/png/binary/G39738WL
T6 1055-1061 Glycan denotes GalNAc https://api.glycosmos.org/wurcs2image/latest/png/binary/G39738WL
T7 1756-1766 Glycan denotes Tn antigen https://api.glycosmos.org/wurcs2image/latest/png/binary/G57321FI

PubmedHPO

Id Subject Object Predicate Lexical cue
T1 267-273 HP_0002664 denotes Cancer
T2 520-526 HP_0002664 denotes cancer
T3 717-723 HP_0002664 denotes cancer
T4 1660-1666 HP_0002664 denotes cancer
T5 1770-1776 HP_0002664 denotes cancer

GlycoBiology-GDGDB

Id Subject Object Predicate Lexical cue
_T1 1314-1316 http://acgg.asia/db/diseases/gdgdb?con_ui=CON00386 denotes nm
_T2 1387-1389 http://acgg.asia/db/diseases/gdgdb?con_ui=CON00386 denotes nm

GlycoBiology-FMA

Id Subject Object Predicate Lexical cue
_T18 1777-1782 FMAID:68646 denotes cells
_T1 128-149 FMAID:167256 denotes glycosylated proteins
_T2 128-149 FMAID:62925 denotes glycosylated proteins
_T3 141-149 FMAID:165447 denotes proteins
_T4 141-149 FMAID:67257 denotes proteins
_T5 348-360 FMAID:82737 denotes carbohydrate
_T6 348-360 FMAID:197276 denotes carbohydrate
_T7 437-449 FMAID:82737 denotes carbohydrate
_T8 437-449 FMAID:197276 denotes carbohydrate
_T9 580-593 FMAID:97740 denotes immune system
_T10 580-593 FMAID:9825 denotes immune system
_T11 997-1002 FMAID:256053 denotes blood
_T12 1168-1172 FMAID:217859 denotes rate
_T13 1249-1259 FMAID:70637 denotes transition
_T14 1249-1259 FMAID:171495 denotes transition
_T15 1615-1627 FMAID:197276 denotes carbohydrate
_T16 1615-1627 FMAID:82737 denotes carbohydrate
_T17 1777-1782 FMAID:169002 denotes cells

uniprot-human

Id Subject Object Predicate Lexical cue
T1 774-777 http://www.uniprot.org/uniprot/Q16305 denotes PSM
T2 823-826 http://www.uniprot.org/uniprot/Q16305 denotes PSM
T3 862-865 http://www.uniprot.org/uniprot/Q16305 denotes PSM
T4 888-891 http://www.uniprot.org/uniprot/Q16305 denotes PSM
T5 1524-1527 http://www.uniprot.org/uniprot/Q16305 denotes PSM
T6 1589-1592 http://www.uniprot.org/uniprot/Q16305 denotes PSM
T7 774-777 http://www.uniprot.org/uniprot/Q9NRF2 denotes PSM
T8 823-826 http://www.uniprot.org/uniprot/Q9NRF2 denotes PSM
T9 862-865 http://www.uniprot.org/uniprot/Q9NRF2 denotes PSM
T10 888-891 http://www.uniprot.org/uniprot/Q9NRF2 denotes PSM
T11 1524-1527 http://www.uniprot.org/uniprot/Q9NRF2 denotes PSM
T12 1589-1592 http://www.uniprot.org/uniprot/Q9NRF2 denotes PSM

uniprot-mouse

Id Subject Object Predicate Lexical cue
T1 774-777 http://www.uniprot.org/uniprot/Q91ZM2 denotes PSM
T2 823-826 http://www.uniprot.org/uniprot/Q91ZM2 denotes PSM
T3 862-865 http://www.uniprot.org/uniprot/Q91ZM2 denotes PSM
T4 888-891 http://www.uniprot.org/uniprot/Q91ZM2 denotes PSM
T5 1524-1527 http://www.uniprot.org/uniprot/Q91ZM2 denotes PSM
T6 1589-1592 http://www.uniprot.org/uniprot/Q91ZM2 denotes PSM

GlycoBiology-NCBITAXON

Id Subject Object Predicate Lexical cue
T1 83-89 http://purl.bioontology.org/ontology/NCBITAXON/6754 denotes cancer
T2 267-273 http://purl.bioontology.org/ontology/NCBITAXON/6754 denotes Cancer
T3 520-526 http://purl.bioontology.org/ontology/NCBITAXON/6754 denotes cancer
T4 527-537 http://purl.bioontology.org/ontology/NCBITAXON/127244 denotes mechanisms
T5 717-723 http://purl.bioontology.org/ontology/NCBITAXON/6754 denotes cancer
T6 1003-1008 http://purl.bioontology.org/ontology/STY/T096 denotes group
T7 1191-1200 http://purl.bioontology.org/ontology/NCBITAXON/68933 denotes thermally
T8 1426-1434 http://purl.bioontology.org/ontology/STY/T033 denotes findings
T9 1660-1666 http://purl.bioontology.org/ontology/NCBITAXON/6754 denotes cancer
T10 1707-1714 http://purl.bioontology.org/ontology/STY/T033 denotes finding
T11 1770-1776 http://purl.bioontology.org/ontology/NCBITAXON/6754 denotes cancer
T12 1777-1782 http://purl.bioontology.org/ontology/STY/T025 denotes cells

GO-BP

Id Subject Object Predicate Lexical cue
T1 128-140 http://purl.obolibrary.org/obo/GO_0070085 denotes glycosylated
T2 128-149 http://purl.obolibrary.org/obo/GO_0006486 denotes glycosylated proteins
T3 193-202 http://purl.obolibrary.org/obo/GO_0023052 denotes signaling
T4 204-217 http://purl.obolibrary.org/obo/GO_0007155 denotes cell adhesion
T5 219-231 http://purl.obolibrary.org/obo/GO_0006954 denotes inflammation
T6 233-248 http://purl.obolibrary.org/obo/GO_0006955 denotes immune response

GO-MF

Id Subject Object Predicate Lexical cue
T1 393-400 http://purl.obolibrary.org/obo/GO_0070026 denotes binding
T2 880-884 http://purl.obolibrary.org/obo/GO_0070026 denotes bind
T3 393-400 http://purl.obolibrary.org/obo/GO_0003680 denotes binding
T4 880-884 http://purl.obolibrary.org/obo/GO_0003680 denotes bind
T5 393-400 http://purl.obolibrary.org/obo/GO_0017091 denotes binding
T6 880-884 http://purl.obolibrary.org/obo/GO_0017091 denotes bind
T7 393-400 http://purl.obolibrary.org/obo/GO_0005488 denotes binding
T8 880-884 http://purl.obolibrary.org/obo/GO_0005488 denotes bind

GO-CC

Id Subject Object Predicate Lexical cue
T1 188-192 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T2 204-208 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T3 1777-1782 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T4 682-685 http://purl.obolibrary.org/obo/GO_0005790 denotes Ser
T5 712-715 http://purl.obolibrary.org/obo/GO_0005790 denotes Ser
T6 990-994 http://purl.obolibrary.org/obo/GO_0019013 denotes core

UBERON-AE

Id Subject Object Predicate Lexical cue
T1 580-593 http://purl.obolibrary.org/obo/UBERON_0002405 denotes immune system
T2 997-1002 http://purl.obolibrary.org/obo/UBERON_0000178 denotes blood

EDAM-topics

Id Subject Object Predicate Lexical cue
T1 7-15 http://edamontology.org/topic_2839 denotes molecule
T2 16-21 http://edamontology.org/topic_3678 denotes study
T3 37-49 http://edamontology.org/topic_0602 denotes interactions
T4 83-89 http://edamontology.org/topic_2640 denotes cancer
T5 90-97 http://edamontology.org/topic_2830 denotes antigen
T6 141-149 http://edamontology.org/topic_0078 denotes proteins
T7 155-168 http://edamontology.org/topic_3300 denotes physiological
T8 267-273 http://edamontology.org/topic_2640 denotes Cancer
T9 348-360 http://edamontology.org/topic_0152 denotes carbohydrate
T10 437-449 http://edamontology.org/topic_0152 denotes carbohydrate
T11 520-526 http://edamontology.org/topic_2640 denotes cancer
T12 621-633 http://edamontology.org/topic_0602 denotes interactions
T13 717-723 http://edamontology.org/topic_2640 denotes cancer
T14 724-732 http://edamontology.org/topic_2830 denotes antigens
T15 784-791 http://edamontology.org/topic_3678 denotes studied
T16 811-821 http://edamontology.org/topic_3382 denotes microscopy
T17 850-857 http://edamontology.org/topic_2830 denotes antigen
T18 942-950 http://edamontology.org/topic_2830 denotes antigens
T19 1111-1123 http://edamontology.org/topic_0602 denotes interactions
T20 1505-1517 http://edamontology.org/topic_0602 denotes interactions
T21 1570-1582 http://edamontology.org/topic_0602 denotes interactions
T22 1615-1627 http://edamontology.org/topic_0152 denotes carbohydrate
T23 1636-1648 http://edamontology.org/topic_0602 denotes interactions
T24 1660-1666 http://edamontology.org/topic_2640 denotes cancer
T25 1667-1674 http://edamontology.org/topic_2830 denotes antigen
T26 1759-1766 http://edamontology.org/topic_2830 denotes antigen
T27 1770-1776 http://edamontology.org/topic_2640 denotes cancer

EDAM-DFO

Id Subject Object Predicate Lexical cue
T1 141-149 http://edamontology.org/format_1208 denotes proteins
T2 141-149 http://edamontology.org/data_1467 denotes proteins
T3 310-316 http://edamontology.org/operation_3435 denotes normal
T4 561-572 http://edamontology.org/operation_2423 denotes recognition
T5 1160-1167 http://edamontology.org/operation_1812 denotes loading
T6 1357-1365 http://edamontology.org/operation_2945 denotes analysis
T7 1410-1418 http://edamontology.org/operation_2945 denotes analysis

GlycoBiology-MAT

Id Subject Object Predicate Lexical cue
T1 997-1002 http://purl.obolibrary.org/obo/MAT_0000315 denotes blood
T2 997-1002 http://purl.obolibrary.org/obo/MAT_0000083 denotes blood

GlycoBiology-Motifs

Id Subject Object Predicate Lexical cue
T1 997-1008 http://rdf.glycoinfo.org/glycan/G00066MO denotes blood group

Lectin

Id Subject Object Predicate Lexical cue
Lectin_T1 80-82 https://acgg.asia/db/lfdb/LfDB0021 denotes Tn
Lectin_T2 667-669 https://acgg.asia/db/lfdb/LfDB0021 denotes Tn
Lectin_T3 847-849 https://acgg.asia/db/lfdb/LfDB0021 denotes Tn
Lectin_T4 859-861 https://acgg.asia/db/lfdb/LfDB0021 denotes Tn
Lectin_T5 931-933 https://acgg.asia/db/lfdb/LfDB0021 denotes Tn
Lectin_T6 1521-1523 https://acgg.asia/db/lfdb/LfDB0021 denotes Tn
Lectin_T7 1586-1588 https://acgg.asia/db/lfdb/LfDB0021 denotes Tn
Lectin_T8 1657-1659 https://acgg.asia/db/lfdb/LfDB0021 denotes Tn
Lectin_T9 1756-1758 https://acgg.asia/db/lfdb/LfDB0021 denotes Tn

GlycoBiology-Epitope

Id Subject Object Predicate Lexical cue
PD-GlycoEpitope-B_T1 847-857 http://www.glycoepitope.jp/epitopes/EP0021 denotes Tn antigen
PD-GlycoEpitope-B_T2 1756-1766 http://www.glycoepitope.jp/epitopes/EP0021 denotes Tn antigen

GlyTouCan-IUPAC

Id Subject Object Predicate Lexical cue
GlycanIUPAC_T1 1066-1069 "http://rdf.glycoinfo.org/glycan/G69371PB" denotes Thr
GlycanIUPAC_T2 1066-1069 "http://rdf.glycoinfo.org/glycan/G04439TG" denotes Thr
GlycanIUPAC_T3 1066-1069 "http://rdf.glycoinfo.org/glycan/G01418RR" denotes Thr
GlycanIUPAC_T4 1066-1069 "http://rdf.glycoinfo.org/glycan/G98605AX" denotes Thr
GlycanIUPAC_T5 1066-1069 "http://rdf.glycoinfo.org/glycan/G24282OK" denotes Thr
GlycanIUPAC_T6 1066-1069 "http://rdf.glycoinfo.org/glycan/G55879EK" denotes Thr
GlycanIUPAC_T7 1066-1069 "http://rdf.glycoinfo.org/glycan/G12116BQ" denotes Thr
GlycanIUPAC_T8 1066-1069 "http://rdf.glycoinfo.org/glycan/G54590PA" denotes Thr
GlycanIUPAC_T9 1066-1069 "http://rdf.glycoinfo.org/glycan/G31652HG" denotes Thr
GlycanIUPAC_T10 1066-1069 "http://rdf.glycoinfo.org/glycan/G15155WL" denotes Thr
GlycanIUPAC_T11 1066-1069 "http://rdf.glycoinfo.org/glycan/G52301ZX" denotes Thr
GlycanIUPAC_T12 1066-1069 "http://rdf.glycoinfo.org/glycan/G04075BC" denotes Thr
GlycanIUPAC_T13 1066-1069 "http://rdf.glycoinfo.org/glycan/G40829OF" denotes Thr
GlycanIUPAC_T14 1066-1069 "http://rdf.glycoinfo.org/glycan/G29274DI" denotes Thr
GlycanIUPAC_T15 1066-1069 "http://rdf.glycoinfo.org/glycan/G50601AY" denotes Thr
GlycanIUPAC_T16 1066-1069 "http://rdf.glycoinfo.org/glycan/G52865ZM" denotes Thr
GlycanIUPAC_T17 1066-1069 "http://rdf.glycoinfo.org/glycan/G73633QJ" denotes Thr
GlycanIUPAC_T18 1066-1069 "http://rdf.glycoinfo.org/glycan/G33319MN" denotes Thr
GlycanIUPAC_T19 1066-1069 "http://rdf.glycoinfo.org/glycan/G94717IQ" denotes Thr
GlycanIUPAC_T20 1066-1069 "http://rdf.glycoinfo.org/glycan/G50452ZL" denotes Thr
GlycanIUPAC_T21 1066-1069 "http://rdf.glycoinfo.org/glycan/G90753WM" denotes Thr
GlycanIUPAC_T22 1066-1069 "http://rdf.glycoinfo.org/glycan/G27898GL" denotes Thr
GlycanIUPAC_T23 1066-1069 "http://rdf.glycoinfo.org/glycan/G03827YH" denotes Thr
GlycanIUPAC_T24 1066-1069 "http://rdf.glycoinfo.org/glycan/G64500BA" denotes Thr
GlycanIUPAC_T25 1066-1069 "http://rdf.glycoinfo.org/glycan/G89743XV" denotes Thr
GlycanIUPAC_T26 1066-1069 "http://rdf.glycoinfo.org/glycan/G62576QG" denotes Thr
GlycanIUPAC_T27 1066-1069 "http://rdf.glycoinfo.org/glycan/G70212CQ" denotes Thr
GlycanIUPAC_T28 1066-1069 "http://rdf.glycoinfo.org/glycan/G74708KP" denotes Thr
GlycanIUPAC_T29 1066-1069 "http://rdf.glycoinfo.org/glycan/G02394PC" denotes Thr
GlycanIUPAC_T30 1066-1069 "http://rdf.glycoinfo.org/glycan/G57814GP" denotes Thr
GlycanIUPAC_T31 1066-1069 "http://rdf.glycoinfo.org/glycan/G81521LC" denotes Thr
GlycanIUPAC_T32 1066-1069 "http://rdf.glycoinfo.org/glycan/G42918SL" denotes Thr
GlycanIUPAC_T33 1066-1069 "http://rdf.glycoinfo.org/glycan/G95238FE" denotes Thr
GlycanIUPAC_T34 1066-1069 "http://rdf.glycoinfo.org/glycan/G28403TD" denotes Thr
GlycanIUPAC_T35 1066-1069 "http://rdf.glycoinfo.org/glycan/G30379UC" denotes Thr
GlycanIUPAC_T36 1066-1069 "http://rdf.glycoinfo.org/glycan/G83583TH" denotes Thr
GlycanIUPAC_T37 1066-1069 "http://rdf.glycoinfo.org/glycan/G59548EJ" denotes Thr
GlycanIUPAC_T38 1066-1069 "http://rdf.glycoinfo.org/glycan/G47410OV" denotes Thr
GlycanIUPAC_T39 1066-1069 "http://rdf.glycoinfo.org/glycan/G88663EK" denotes Thr
GlycanIUPAC_T40 1066-1069 "http://rdf.glycoinfo.org/glycan/G90684PG" denotes Thr
GlycanIUPAC_T41 1066-1069 "http://rdf.glycoinfo.org/glycan/G44881OW" denotes Thr
GlycanIUPAC_T42 1066-1069 "http://rdf.glycoinfo.org/glycan/G54691YO" denotes Thr
GlycanIUPAC_T43 1066-1069 "http://rdf.glycoinfo.org/glycan/G19289PT" denotes Thr
GlycanIUPAC_T44 1066-1069 "http://rdf.glycoinfo.org/glycan/G23779KC" denotes Thr
GlycanIUPAC_T45 1066-1069 "http://rdf.glycoinfo.org/glycan/G94729UX" denotes Thr
GlycanIUPAC_T46 1066-1069 "http://rdf.glycoinfo.org/glycan/G34038TZ" denotes Thr
GlycanIUPAC_T47 1066-1069 "http://rdf.glycoinfo.org/glycan/G90659JR" denotes Thr
GlycanIUPAC_T48 1066-1069 "http://rdf.glycoinfo.org/glycan/G74977VW" denotes Thr
GlycanIUPAC_T49 1066-1069 "http://rdf.glycoinfo.org/glycan/G42696WA" denotes Thr
GlycanIUPAC_T50 1066-1069 "http://rdf.glycoinfo.org/glycan/G82531XS" denotes Thr
GlycanIUPAC_T51 1066-1069 "http://rdf.glycoinfo.org/glycan/G47639GO" denotes Thr
GlycanIUPAC_T52 1066-1069 "http://rdf.glycoinfo.org/glycan/G69282NX" denotes Thr
GlycanIUPAC_T53 1066-1069 "http://rdf.glycoinfo.org/glycan/G49708JS" denotes Thr
GlycanIUPAC_T54 1066-1069 "http://rdf.glycoinfo.org/glycan/G63317ON" denotes Thr
GlycanIUPAC_T55 1066-1069 "http://rdf.glycoinfo.org/glycan/G60349YI" denotes Thr
GlycanIUPAC_T56 1066-1069 "http://rdf.glycoinfo.org/glycan/G81659AQ" denotes Thr
GlycanIUPAC_T57 1066-1069 "http://rdf.glycoinfo.org/glycan/G16289GE" denotes Thr
GlycanIUPAC_T58 1066-1069 "http://rdf.glycoinfo.org/glycan/G69569AG" denotes Thr
GlycanIUPAC_T59 1066-1069 "http://rdf.glycoinfo.org/glycan/G16884LK" denotes Thr
GlycanIUPAC_T60 1066-1069 "http://rdf.glycoinfo.org/glycan/G23450NH" denotes Thr
GlycanIUPAC_T61 1066-1069 "http://rdf.glycoinfo.org/glycan/G85052FR" denotes Thr
GlycanIUPAC_T62 1066-1069 "http://rdf.glycoinfo.org/glycan/G55485RI" denotes Thr
GlycanIUPAC_T63 1066-1069 "http://rdf.glycoinfo.org/glycan/G80596GL" denotes Thr
GlycanIUPAC_T64 1066-1069 "http://rdf.glycoinfo.org/glycan/G39656RU" denotes Thr
GlycanIUPAC_T65 1066-1069 "http://rdf.glycoinfo.org/glycan/G71284FA" denotes Thr
GlycanIUPAC_T66 1066-1069 "http://rdf.glycoinfo.org/glycan/G42091PK" denotes Thr
GlycanIUPAC_T67 1066-1069 "http://rdf.glycoinfo.org/glycan/G38798SL" denotes Thr
GlycanIUPAC_T68 1066-1069 "http://rdf.glycoinfo.org/glycan/G36670NA" denotes Thr
GlycanIUPAC_T69 1066-1069 "http://rdf.glycoinfo.org/glycan/G91582QV" denotes Thr
GlycanIUPAC_T70 1066-1069 "http://rdf.glycoinfo.org/glycan/G28625IE" denotes Thr
GlycanIUPAC_T71 1066-1069 "http://rdf.glycoinfo.org/glycan/G81304ZT" denotes Thr
GlycanIUPAC_T72 1066-1069 "http://rdf.glycoinfo.org/glycan/G82883BK" denotes Thr
GlycanIUPAC_T73 1066-1069 "http://rdf.glycoinfo.org/glycan/G46290DK" denotes Thr
GlycanIUPAC_T74 1066-1069 "http://rdf.glycoinfo.org/glycan/G68202TJ" denotes Thr
GlycanIUPAC_T75 1066-1069 "http://rdf.glycoinfo.org/glycan/G39722QK" denotes Thr
GlycanIUPAC_T76 1066-1069 "http://rdf.glycoinfo.org/glycan/G76637LW" denotes Thr
GlycanIUPAC_T77 1066-1069 "http://rdf.glycoinfo.org/glycan/G51390WF" denotes Thr
GlycanIUPAC_T78 1066-1069 "http://rdf.glycoinfo.org/glycan/G35392PX" denotes Thr
GlycanIUPAC_T79 1066-1069 "http://rdf.glycoinfo.org/glycan/G27815EZ" denotes Thr
GlycanIUPAC_T80 1066-1069 "http://rdf.glycoinfo.org/glycan/G64374OT" denotes Thr
GlycanIUPAC_T81 1066-1069 "http://rdf.glycoinfo.org/glycan/G58333PU" denotes Thr
GlycanIUPAC_T82 1066-1069 "http://rdf.glycoinfo.org/glycan/G19695IE" denotes Thr
GlycanIUPAC_T83 1066-1069 "http://rdf.glycoinfo.org/glycan/G65617GK" denotes Thr
GlycanIUPAC_T84 1066-1069 "http://rdf.glycoinfo.org/glycan/G29832KZ" denotes Thr
GlycanIUPAC_T85 1066-1069 "http://rdf.glycoinfo.org/glycan/G05333AM" denotes Thr
GlycanIUPAC_T86 1066-1069 "http://rdf.glycoinfo.org/glycan/G46130CG" denotes Thr
GlycanIUPAC_T87 1066-1069 "http://rdf.glycoinfo.org/glycan/G57766RG" denotes Thr
GlycanIUPAC_T88 1066-1069 "http://rdf.glycoinfo.org/glycan/G03334HH" denotes Thr
GlycanIUPAC_T89 1066-1069 "http://rdf.glycoinfo.org/glycan/G46094SV" denotes Thr
GlycanIUPAC_T90 1066-1069 "http://rdf.glycoinfo.org/glycan/G98365FX" denotes Thr
GlycanIUPAC_T91 1066-1069 "http://rdf.glycoinfo.org/glycan/G85392EJ" denotes Thr
GlycanIUPAC_T92 1066-1069 "http://rdf.glycoinfo.org/glycan/G59996WL" denotes Thr
GlycanIUPAC_T93 1066-1069 "http://rdf.glycoinfo.org/glycan/G49141OD" denotes Thr
GlycanIUPAC_T94 1066-1069 "http://rdf.glycoinfo.org/glycan/G88793VU" denotes Thr
GlycanIUPAC_T95 1066-1069 "http://rdf.glycoinfo.org/glycan/G88801WQ" denotes Thr
GlycanIUPAC_T96 1066-1069 "http://rdf.glycoinfo.org/glycan/G61612EQ" denotes Thr
GlycanIUPAC_T97 1066-1069 "http://rdf.glycoinfo.org/glycan/G23181BS" denotes Thr
GlycanIUPAC_T98 1066-1069 "http://rdf.glycoinfo.org/glycan/G77428YW" denotes Thr
GlycanIUPAC_T99 1066-1069 "http://rdf.glycoinfo.org/glycan/G06824UZ" denotes Thr
GlycanIUPAC_T100 1066-1069 "http://rdf.glycoinfo.org/glycan/G15142RK" denotes Thr
GlycanIUPAC_T101 1066-1069 "http://rdf.glycoinfo.org/glycan/G18198RM" denotes Thr
GlycanIUPAC_T102 1066-1069 "http://rdf.glycoinfo.org/glycan/G70750SS" denotes Thr
GlycanIUPAC_T103 1066-1069 "http://rdf.glycoinfo.org/glycan/G04998YJ" denotes Thr
GlycanIUPAC_T104 1066-1069 "http://rdf.glycoinfo.org/glycan/G44379HX" denotes Thr
GlycanIUPAC_T105 1066-1069 "http://rdf.glycoinfo.org/glycan/G25683ZO" denotes Thr
GlycanIUPAC_T106 1066-1069 "http://rdf.glycoinfo.org/glycan/G35036BA" denotes Thr
GlycanIUPAC_T107 1066-1069 "http://rdf.glycoinfo.org/glycan/G98129RB" denotes Thr
GlycanIUPAC_T108 1066-1069 "http://rdf.glycoinfo.org/glycan/G00134PL" denotes Thr
GlycanIUPAC_T109 1066-1069 "http://rdf.glycoinfo.org/glycan/G26488SP" denotes Thr
GlycanIUPAC_T110 1066-1069 "http://rdf.glycoinfo.org/glycan/G02441UD" denotes Thr
GlycanIUPAC_T111 1066-1069 "http://rdf.glycoinfo.org/glycan/G21668ZD" denotes Thr
GlycanIUPAC_T112 1066-1069 "http://rdf.glycoinfo.org/glycan/G67040OT" denotes Thr
GlycanIUPAC_T113 1066-1069 "http://rdf.glycoinfo.org/glycan/G56431YZ" denotes Thr
GlycanIUPAC_T114 1066-1069 "http://rdf.glycoinfo.org/glycan/G29667IS" denotes Thr
GlycanIUPAC_T115 1066-1069 "http://rdf.glycoinfo.org/glycan/G94122LM" denotes Thr
GlycanIUPAC_T116 1066-1069 "http://rdf.glycoinfo.org/glycan/G93233YT" denotes Thr
GlycanIUPAC_T117 1066-1069 "http://rdf.glycoinfo.org/glycan/G72035WK" denotes Thr
GlycanIUPAC_T118 1066-1069 "http://rdf.glycoinfo.org/glycan/G99855SM" denotes Thr
GlycanIUPAC_T119 1066-1069 "http://rdf.glycoinfo.org/glycan/G48723MN" denotes Thr
GlycanIUPAC_T120 1066-1069 "http://rdf.glycoinfo.org/glycan/G28558MB" denotes Thr
GlycanIUPAC_T121 1066-1069 "http://rdf.glycoinfo.org/glycan/G92768RX" denotes Thr
GlycanIUPAC_T122 1066-1069 "http://rdf.glycoinfo.org/glycan/G70136KU" denotes Thr
GlycanIUPAC_T123 1066-1069 "http://rdf.glycoinfo.org/glycan/G37935YM" denotes Thr
GlycanIUPAC_T124 1066-1069 "http://rdf.glycoinfo.org/glycan/G96902PQ" denotes Thr
GlycanIUPAC_T125 1066-1069 "http://rdf.glycoinfo.org/glycan/G14015DN" denotes Thr
GlycanIUPAC_T126 1066-1069 "http://rdf.glycoinfo.org/glycan/G83153IV" denotes Thr
GlycanIUPAC_T127 1066-1069 "http://rdf.glycoinfo.org/glycan/G73174QP" denotes Thr
GlycanIUPAC_T128 1066-1069 "http://rdf.glycoinfo.org/glycan/G67188XY" denotes Thr
GlycanIUPAC_T129 1066-1069 "http://rdf.glycoinfo.org/glycan/G35093GE" denotes Thr
GlycanIUPAC_T130 1066-1069 "http://rdf.glycoinfo.org/glycan/G13364VQ" denotes Thr
GlycanIUPAC_T131 1066-1069 "http://rdf.glycoinfo.org/glycan/G72068FB" denotes Thr
GlycanIUPAC_T132 1066-1069 "http://rdf.glycoinfo.org/glycan/G93329DU" denotes Thr
GlycanIUPAC_T133 1066-1069 "http://rdf.glycoinfo.org/glycan/G54073VB" denotes Thr
GlycanIUPAC_T134 1066-1069 "http://rdf.glycoinfo.org/glycan/G41447UI" denotes Thr
GlycanIUPAC_T135 1066-1069 "http://rdf.glycoinfo.org/glycan/G85878MY" denotes Thr
GlycanIUPAC_T136 1066-1069 "http://rdf.glycoinfo.org/glycan/G92835HR" denotes Thr
GlycanIUPAC_T137 1066-1069 "http://rdf.glycoinfo.org/glycan/G34845TQ" denotes Thr
GlycanIUPAC_T138 1066-1069 "http://rdf.glycoinfo.org/glycan/G38916XK" denotes Thr
GlycanIUPAC_T139 1066-1069 "http://rdf.glycoinfo.org/glycan/G87709OA" denotes Thr
GlycanIUPAC_T140 1066-1069 "http://rdf.glycoinfo.org/glycan/G46661GX" denotes Thr
GlycanIUPAC_T141 1066-1069 "http://rdf.glycoinfo.org/glycan/G53431DX" denotes Thr
GlycanIUPAC_T142 1066-1069 "http://rdf.glycoinfo.org/glycan/G71815PL" denotes Thr
GlycanIUPAC_T143 1066-1069 "http://rdf.glycoinfo.org/glycan/G97173UR" denotes Thr
GlycanIUPAC_T144 1066-1069 "http://rdf.glycoinfo.org/glycan/G53453JD" denotes Thr
GlycanIUPAC_T145 1066-1069 "http://rdf.glycoinfo.org/glycan/G48975CP" denotes Thr
GlycanIUPAC_T146 1066-1069 "http://rdf.glycoinfo.org/glycan/G87775XT" denotes Thr
GlycanIUPAC_T147 1066-1069 "http://rdf.glycoinfo.org/glycan/G48463GY" denotes Thr
GlycanIUPAC_T148 1066-1069 "http://rdf.glycoinfo.org/glycan/G54042BQ" denotes Thr
GlycanIUPAC_T149 1066-1069 "http://rdf.glycoinfo.org/glycan/G99993MV" denotes Thr
GlycanIUPAC_T150 1066-1069 "http://rdf.glycoinfo.org/glycan/G81407LL" denotes Thr
GlycanIUPAC_T151 1066-1069 "http://rdf.glycoinfo.org/glycan/G46430YF" denotes Thr
GlycanIUPAC_T152 1066-1069 "http://rdf.glycoinfo.org/glycan/G86548QQ" denotes Thr
GlycanIUPAC_T153 1066-1069 "http://rdf.glycoinfo.org/glycan/G25645HZ" denotes Thr
GlycanIUPAC_T154 1066-1069 "http://rdf.glycoinfo.org/glycan/G73880WZ" denotes Thr
GlycanIUPAC_T155 1066-1069 "http://rdf.glycoinfo.org/glycan/G12979RT" denotes Thr
GlycanIUPAC_T156 1066-1069 "http://rdf.glycoinfo.org/glycan/G36146RU" denotes Thr
GlycanIUPAC_T157 1066-1069 "http://rdf.glycoinfo.org/glycan/G23944RZ" denotes Thr
GlycanIUPAC_T158 1066-1069 "http://rdf.glycoinfo.org/glycan/G67041BN" denotes Thr
GlycanIUPAC_T159 1066-1069 "http://rdf.glycoinfo.org/glycan/G95408HX" denotes Thr
GlycanIUPAC_T160 1066-1069 "http://rdf.glycoinfo.org/glycan/G31094CC" denotes Thr
GlycanIUPAC_T161 1066-1069 "http://rdf.glycoinfo.org/glycan/G99598GU" denotes Thr
GlycanIUPAC_T162 1066-1069 "http://rdf.glycoinfo.org/glycan/G94072IC" denotes Thr
GlycanIUPAC_T163 1066-1069 "http://rdf.glycoinfo.org/glycan/G09523ZS" denotes Thr

performance-test

Id Subject Object Predicate Lexical cue
PD-UBERON-AE-B_T1 997-1002 http://purl.obolibrary.org/obo/UBERON_0000178 denotes blood
PD-UBERON-AE-B_T2 580-593 http://purl.obolibrary.org/obo/UBERON_0002405 denotes immune system

mondo_disease

Id Subject Object Predicate Lexical cue mondo_id
T1 83-89 Disease denotes cancer http://purl.obolibrary.org/obo/MONDO_0004992
T2 219-231 Disease denotes inflammation http://purl.obolibrary.org/obo/MONDO_0021166
T3 267-273 Disease denotes Cancer http://purl.obolibrary.org/obo/MONDO_0004992
T4 520-526 Disease denotes cancer http://purl.obolibrary.org/obo/MONDO_0004992
T5 717-723 Disease denotes cancer http://purl.obolibrary.org/obo/MONDO_0004992
T6 1660-1666 Disease denotes cancer http://purl.obolibrary.org/obo/MONDO_0004992
T7 1770-1776 Disease denotes cancer http://purl.obolibrary.org/obo/MONDO_0004992

Anatomy-MAT

Id Subject Object Predicate Lexical cue mat_id
T1 997-1002 Body_part denotes blood http://purl.obolibrary.org/obo/MAT_0000083|http://purl.obolibrary.org/obo/MAT_0000315

HP-phenotype

Id Subject Object Predicate Lexical cue hp_id
T1 83-89 Phenotype denotes cancer HP:0002664
T2 267-273 Phenotype denotes Cancer HP:0002664
T3 520-526 Phenotype denotes cancer HP:0002664
T4 717-723 Phenotype denotes cancer HP:0002664
T5 1660-1666 Phenotype denotes cancer HP:0002664
T6 1770-1776 Phenotype denotes cancer HP:0002664

GlyCosmos15-HP

Id Subject Object Predicate Lexical cue hp_id
T1 83-89 Phenotype denotes cancer HP:0002664
T2 267-273 Phenotype denotes Cancer HP:0002664
T3 520-526 Phenotype denotes cancer HP:0002664
T4 717-723 Phenotype denotes cancer HP:0002664
T5 1660-1666 Phenotype denotes cancer HP:0002664
T6 1770-1776 Phenotype denotes cancer HP:0002664

GlyCosmos15-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T1 83-89 Disease denotes cancer MONDO:0004992
T2 267-273 Disease denotes Cancer MONDO:0004992
T3 520-526 Disease denotes cancer MONDO:0004992
T4 717-723 Disease denotes cancer MONDO:0004992
T5 1660-1666 Disease denotes cancer MONDO:0004992
T6 1770-1776 Disease denotes cancer MONDO:0004992

GlyCosmos15-CL

Id Subject Object Predicate Lexical cue cl_id
T1 1770-1782 Cell denotes cancer cells http://purl.obolibrary.org/obo/CL:0001064

GlyCosmos15-UBERON

Id Subject Object Predicate Lexical cue uberon_id
T1 580-593 Body_part denotes immune system http://purl.obolibrary.org/obo/UBERON_0002405
T2 997-1002 Body_part denotes blood http://purl.obolibrary.org/obo/UBERON_0000178

sentences

Id Subject Object Predicate Lexical cue
TextSentencer_T1 0-98 Sentence denotes Single molecule study of heterotypic interactions between mucins possessing the Tn cancer antigen.
TextSentencer_T2 99-266 Sentence denotes Mucins are linear, heavily O-glycosylated proteins with physiological roles that include cell signaling, cell adhesion, inflammation, immune response and tumorgenesis.
TextSentencer_T3 267-368 Sentence denotes Cancer-associated mucins often differ from normal mucins by presenting truncated carbohydrate chains.
TextSentencer_T4 369-594 Sentence denotes Characterization of the binding properties of mucins with truncated carbohydrate side chains could thus prove relevant for understanding their role in cancer mechanisms such as metastasis and recognition by the immune system.
TextSentencer_T5 595-822 Sentence denotes In this work, heterotypic interactions of model mucins that possess the Tn (GalNAcαThr/Ser) and T (Galβ1-3GalNAcαThr/Ser) cancer antigens derived from porcine submaxillary mucin (PSM) were studied using atomic force microscopy.
TextSentencer_T6 823-1071 Sentence denotes PSM possessing only the Tn antigen (Tn-PSM) was found to bind to PSM analogs possessing a combination of T, Tn and STn antigens as well as biosynthetic analogs of the core 1 blood group A tetrasaccharide (GalNAcα1-3[Fucα1-2] Galβ1-3GalNAcαSer/Thr).
TextSentencer_T7 1072-1186 Sentence denotes The rupture forces for the heterotypic interactions ranged from 18- to 31 pN at a force-loading rate of ∼0.5 nN/s.
TextSentencer_T8 1187-1419 Sentence denotes The thermally averaged distance from the bound complex to the transition state (xβ) was estimated to be in the range 0.37-0.87 nm for the first barrier of the Bell Evans analysis and within 0.34-0.64 nm based on a lifetime analysis.
TextSentencer_T9 1420-1593 Sentence denotes These findings reveal that the binding strength and energy landscape for heterotypic interactions of Tn-PSM with the above mucins, resemble homotypic interactions of Tn-PSM.
TextSentencer_T10 1594-1783 Sentence denotes This suggests common carbohydrate epitope interactions for the Tn cancer antigen with the above mucin analogs, a finding that may be important to the role of the Tn antigen in cancer cells.
T1 0-98 Sentence denotes Single molecule study of heterotypic interactions between mucins possessing the Tn cancer antigen.
T2 99-266 Sentence denotes Mucins are linear, heavily O-glycosylated proteins with physiological roles that include cell signaling, cell adhesion, inflammation, immune response and tumorgenesis.
T3 267-368 Sentence denotes Cancer-associated mucins often differ from normal mucins by presenting truncated carbohydrate chains.
T4 369-594 Sentence denotes Characterization of the binding properties of mucins with truncated carbohydrate side chains could thus prove relevant for understanding their role in cancer mechanisms such as metastasis and recognition by the immune system.
T5 595-822 Sentence denotes In this work, heterotypic interactions of model mucins that possess the Tn (GalNAcαThr/Ser) and T (Galβ1-3GalNAcαThr/Ser) cancer antigens derived from porcine submaxillary mucin (PSM) were studied using atomic force microscopy.
T6 823-1071 Sentence denotes PSM possessing only the Tn antigen (Tn-PSM) was found to bind to PSM analogs possessing a combination of T, Tn and STn antigens as well as biosynthetic analogs of the core 1 blood group A tetrasaccharide (GalNAcα1-3[Fucα1-2] Galβ1-3GalNAcαSer/Thr).
T7 1072-1186 Sentence denotes The rupture forces for the heterotypic interactions ranged from 18- to 31 pN at a force-loading rate of ∼0.5 nN/s.
T8 1187-1419 Sentence denotes The thermally averaged distance from the bound complex to the transition state (xβ) was estimated to be in the range 0.37-0.87 nm for the first barrier of the Bell Evans analysis and within 0.34-0.64 nm based on a lifetime analysis.
T9 1420-1593 Sentence denotes These findings reveal that the binding strength and energy landscape for heterotypic interactions of Tn-PSM with the above mucins, resemble homotypic interactions of Tn-PSM.
T10 1594-1783 Sentence denotes This suggests common carbohydrate epitope interactions for the Tn cancer antigen with the above mucin analogs, a finding that may be important to the role of the Tn antigen in cancer cells.
T1 0-98 Sentence denotes Single molecule study of heterotypic interactions between mucins possessing the Tn cancer antigen.
T2 99-266 Sentence denotes Mucins are linear, heavily O-glycosylated proteins with physiological roles that include cell signaling, cell adhesion, inflammation, immune response and tumorgenesis.
T3 267-368 Sentence denotes Cancer-associated mucins often differ from normal mucins by presenting truncated carbohydrate chains.
T4 369-594 Sentence denotes Characterization of the binding properties of mucins with truncated carbohydrate side chains could thus prove relevant for understanding their role in cancer mechanisms such as metastasis and recognition by the immune system.
T5 595-822 Sentence denotes In this work, heterotypic interactions of model mucins that possess the Tn (GalNAcαThr/Ser) and T (Galβ1-3GalNAcαThr/Ser) cancer antigens derived from porcine submaxillary mucin (PSM) were studied using atomic force microscopy.
T6 823-1071 Sentence denotes PSM possessing only the Tn antigen (Tn-PSM) was found to bind to PSM analogs possessing a combination of T, Tn and STn antigens as well as biosynthetic analogs of the core 1 blood group A tetrasaccharide (GalNAcα1-3[Fucα1-2] Galβ1-3GalNAcαSer/Thr).
T7 1072-1186 Sentence denotes The rupture forces for the heterotypic interactions ranged from 18- to 31 pN at a force-loading rate of ∼0.5 nN/s.
T8 1187-1419 Sentence denotes The thermally averaged distance from the bound complex to the transition state (xβ) was estimated to be in the range 0.37-0.87 nm for the first barrier of the Bell Evans analysis and within 0.34-0.64 nm based on a lifetime analysis.
T9 1420-1593 Sentence denotes These findings reveal that the binding strength and energy landscape for heterotypic interactions of Tn-PSM with the above mucins, resemble homotypic interactions of Tn-PSM.
T10 1594-1783 Sentence denotes This suggests common carbohydrate epitope interactions for the Tn cancer antigen with the above mucin analogs, a finding that may be important to the role of the Tn antigen in cancer cells.

GlyCosmos15-Sentences

Id Subject Object Predicate Lexical cue
T1 0-98 Sentence denotes Single molecule study of heterotypic interactions between mucins possessing the Tn cancer antigen.
T2 99-266 Sentence denotes Mucins are linear, heavily O-glycosylated proteins with physiological roles that include cell signaling, cell adhesion, inflammation, immune response and tumorgenesis.
T3 267-368 Sentence denotes Cancer-associated mucins often differ from normal mucins by presenting truncated carbohydrate chains.
T4 369-594 Sentence denotes Characterization of the binding properties of mucins with truncated carbohydrate side chains could thus prove relevant for understanding their role in cancer mechanisms such as metastasis and recognition by the immune system.
T5 595-822 Sentence denotes In this work, heterotypic interactions of model mucins that possess the Tn (GalNAcαThr/Ser) and T (Galβ1-3GalNAcαThr/Ser) cancer antigens derived from porcine submaxillary mucin (PSM) were studied using atomic force microscopy.
T6 823-1071 Sentence denotes PSM possessing only the Tn antigen (Tn-PSM) was found to bind to PSM analogs possessing a combination of T, Tn and STn antigens as well as biosynthetic analogs of the core 1 blood group A tetrasaccharide (GalNAcα1-3[Fucα1-2] Galβ1-3GalNAcαSer/Thr).
T7 1072-1186 Sentence denotes The rupture forces for the heterotypic interactions ranged from 18- to 31 pN at a force-loading rate of ∼0.5 nN/s.
T8 1187-1419 Sentence denotes The thermally averaged distance from the bound complex to the transition state (xβ) was estimated to be in the range 0.37-0.87 nm for the first barrier of the Bell Evans analysis and within 0.34-0.64 nm based on a lifetime analysis.
T9 1420-1593 Sentence denotes These findings reveal that the binding strength and energy landscape for heterotypic interactions of Tn-PSM with the above mucins, resemble homotypic interactions of Tn-PSM.
T10 1594-1783 Sentence denotes This suggests common carbohydrate epitope interactions for the Tn cancer antigen with the above mucin analogs, a finding that may be important to the role of the Tn antigen in cancer cells.

GlyCosmos15-GlycoEpitope

Id Subject Object Predicate Lexical cue glycoepitope_id
T1 847-857 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes Tn antigen http://www.glycoepitope.jp/epitopes/EP0021
T2 1756-1766 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes Tn antigen http://www.glycoepitope.jp/epitopes/EP0021

GlyCosmos15-FMA

Id Subject Object Predicate Lexical cue db_id
T1 580-593 Body_part denotes immune system FMA:9825
T2 997-1002 Body_part denotes blood FMA:9670

GlyCosmos15-MAT

Id Subject Object Predicate Lexical cue mat_id
T1 997-1002 Body_part denotes blood http://purl.obolibrary.org/obo/MAT_0000315

GlyCosmos15-Glycan

Id Subject Object Predicate Lexical cue image
T1 671-677 Glycan denotes GalNAc https://api.glycosmos.org/wurcs2image/latest/png/binary/G39738WL
T2 701-707 Glycan denotes GalNAc https://api.glycosmos.org/wurcs2image/latest/png/binary/G39738WL
T3 847-857 Glycan denotes Tn antigen https://api.glycosmos.org/wurcs2image/latest/png/binary/G57321FI
T4 990-996 Glycan denotes core 1 https://api.glycosmos.org/wurcs2image/latest/png/binary/G00031MO
T5 997-1010 Glycan denotes blood group A https://api.glycosmos.org/wurcs2image/latest/png/binary/G00066MO
T6 1028-1034 Glycan denotes GalNAc https://api.glycosmos.org/wurcs2image/latest/png/binary/G39738WL
T7 1055-1061 Glycan denotes GalNAc https://api.glycosmos.org/wurcs2image/latest/png/binary/G39738WL
T8 1756-1766 Glycan denotes Tn antigen https://api.glycosmos.org/wurcs2image/latest/png/binary/G57321FI

GlyCosmos-GlycoEpitope

Id Subject Object Predicate Lexical cue glycoepitope_id
T1 847-857 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes Tn antigen http://www.glycoepitope.jp/epitopes/EP0021
T2 1756-1766 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes Tn antigen http://www.glycoepitope.jp/epitopes/EP0021

Anatomy-UBERON

Id Subject Object Predicate Lexical cue uberon_id
T1 580-593 Body_part denotes immune system http://purl.obolibrary.org/obo/UBERON_0002405
T2 997-1002 Body_part denotes blood http://purl.obolibrary.org/obo/UBERON_0000178

CL-cell

Id Subject Object Predicate Lexical cue cl_id
T1 1770-1782 Cell denotes cancer cells http://purl.obolibrary.org/obo/CL:0001064